HS
AVXL icon

Horan Securities’s Anavex Life Sciences AVXL Stock Holding History

Horan Securities’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-200
Closed -$1.63K – 139
2023
Q2 		$1.63K Hold
200
– – ﹤0.01% 587
2023
Q1 		$1.71K Hold
200
– – ﹤0.01% 576
2022
Q4 		$1.85K Hold
200
– – ﹤0.01% 567
2022
Q3 		$2K Hold
200
– – ﹤0.01% 469
2022
Q2 		$2K Hold
200
– – ﹤0.01% 525
2022
Q1 		$2K Hold
200
– – ﹤0.01% 440
2021
Q4 		$3K Buy
+200
New +$3.8K ﹤0.01% 419
2021
Q2 		$5K Hold
200
– – ﹤0.01% 353
2021
Q1 		$3K Buy
+200
New +$2.18K ﹤0.01% 343

Other funds holding AVXL

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $77.3B AUM 36.07% 1-Year Est. Return